RhumbLine Advisers
PRAX icon

RhumbLine Advisers’s Praxis Precision Medicines PRAX Stock Holding History

RhumbLine Advisers’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8M Sell
32,347
-532
-2% -$168K 0.01% 1060
2026
Q1 		$10.6M Buy
32,879
+4,555
+16% +$1.41M 0.01% 1030
2025
Q4 		$8.35M Buy
28,324
+1,530
+6% +$285K 0.01% 1148
2025
Q3 		$1.42M Sell
26,794
-547
-2% -$26.5K ﹤0.01% 2073
2025
Q2 		$1.15M Buy
27,341
+3,047
+13% +$116K ﹤0.01% 2176
2025
Q1 		$920K Buy
24,294
+1,525
+7% +$95.2K ﹤0.01% 2215
2024
Q4 		$1.75M Sell
22,769
-347
-2% -$25.1K ﹤0.01% 1957
2024
Q3 		$1.33M Buy
23,116
+924
+4% +$49.9K ﹤0.01% 2115
2024
Q2 		$918K Buy
22,192
+22,040
+14,500% +$1.04M ﹤0.01% 2300
2024
Q1 		$9.28K Hold
152
– – ﹤0.01% 3882
2023
Q4 		$3.39K Hold
152
– – ﹤0.01% 4040
2023
Q3 		$3.91K Sell
152
-88
-37% -$1.67K ﹤0.01% 4022
2023
Q2 		$4.14K Sell
240
-3,984
-94% -$61K ﹤0.01% 4120
2023
Q1 		$51K Buy
4,224
+527
+14% +$22.2K ﹤0.01% 2906
2022
Q4 		$132K Buy
3,697
+18
+0.5% +$561 ﹤0.01% 2866
2022
Q3 		$125K Buy
3,679
+448
+14% +$22.3K ﹤0.01% 2979
2022
Q2 		$119K Buy
3,231
+473
+17% +$50.5K ﹤0.01% 3018
2022
Q1 		$422K Buy
2,758
+231
+9% +$47.5K ﹤0.01% 2496
2021
Q4 		$747K Buy
2,527
+151
+6% +$44.3K ﹤0.01% 2335
2021
Q3 		$659K Buy
2,376
+438
+23% +$119K ﹤0.01% 2426
2021
Q2 		$531K Buy
1,938
+1,232
+175% +$441K ﹤0.01% 2537
2021
Q1 		$347K Buy
706
+34
+5% +$24.2K ﹤0.01% 2646
2020
Q4 		$555K Buy
+672
New +$392K ﹤0.01% 2400

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

RhumbLine Advisers's PRAX Position: Q2 2026 in Review

RhumbLine Advisers reduced its Praxis Precision Medicines (PRAX) stake by 1.6% in Q2 2026, selling an estimated $168K and leaving 32,347 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #1060.

RhumbLine Advisers first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • RhumbLine Advisers held 32,347 shares of Praxis Precision Medicines worth $10.8M as of Q2 2026.
  • RhumbLine Advisers sold 532 Praxis Precision Medicines shares in Q2 2026, an estimated $168K.
  • Praxis Precision Medicines made up 0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #1060 holding.
  • RhumbLine Advisers first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.